SEMA4F Inhibitors belong to a specific chemical class that has garnered considerable attention in the field of molecular biology and cellular signaling research. These compounds are designed to target and inhibit the activity of SEMA4F, a protein involved in a diverse array of cellular processes. SEMA4F, short for Semaphorin 4F, is a member of the semaphorin family of proteins, which are primarily known for their crucial roles in axon guidance and neural development. SEMA4F, however, has a distinct set of functions beyond the nervous system, making it an intriguing target for study.
SEMA4F is to act as a signaling molecule, participating in cell-cell communication and tissue development. It is particularly recognized for its involvement in immune response regulation, where it can influence the behavior of immune cells such as T cells and macrophages. SEMA4F Inhibitors are designed to interfere with the signaling pathways mediated by SEMA4F, ultimately affecting various cellular responses. Understanding the precise mechanisms of SEMA4F and its inhibitors can provide valuable insights into fundamental cellular processes. Researchers are actively exploring the potential of SEMA4F Inhibitors to dissect these complex cellular pathways and gain a deeper understanding of their intricate roles in various physiological contexts.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $153.00 $938.00 | 5 | |
A receptor tyrosine kinase inhibitor that can affect SEMA4F signaling by inhibiting VEGF receptors, which are part of the same pathway. | ||||||
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $87.00 $135.00 $293.00 $505.00 $3827.00 | 42 | |
A selective inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase that may indirectly affect SEMA4F signaling through EGFR-related pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that can alter downstream signaling of SEMA4F by affecting the PI3K/Akt pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An inhibitor of MEK, which can indirectly affect SEMA4F signaling through inhibition of the MAPK/ERK pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor that may alter SEMA4F signaling through effects on the JNK pathway, which is associated with cellular growth and differentiation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that may modify SEMA4F signaling by affecting inflammatory responses and other p38 MAPK-regulated processes. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor like LY294002, which can disrupt SEMA4F-related pathways by inhibiting the PI3K/Akt signaling cascade. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
A Src family kinase inhibitor that can modulate SEMA4F signaling through effects on Src kinases, which interact with various signaling pathways. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
A broad-spectrum tyrosine kinase inhibitor that can influence SEMA4F signaling indirectly by targeting multiple kinases, including Src family kinases. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that may impact SEMA4F signaling by affecting the mTOR pathway, which is involved in cell growth and proliferation. | ||||||